Sunday November 22 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Grant Life Sciences

Dr. Hun-Chi Lin, President, CSO and Director - Since 2003, Dr. Hun-Chi Lin was a co-founder and President of XepMed, Inc., which develops medical devices used for separating blood components and treating infectious diseases. From 1999 to present, Dr. Lin was a co-founder and President of BioMedical Research Laboratories, Inc., which developed a Web-based healthcare partner-connectivity system to be used by individual health maintenance organizations, individuals, and in clinical trials. From 1996 to 1999, Dr. Lin was Director of Clinical Trials at Specialty Laboratories (NYSE: SP - News), where he built and managed a clinical trials division that had the broadest esoteric-testing capabilities in the CRO (Contract Research Organization) industry. Michael L. Ahlin, MBA, VP & Director - Mr. Michael Ahlin is a founding member of Impact Diagnostics, with thirty years executive experience. Mr. Ahlin has been instrumental in founding and developing seven companies, including two biotech entities. Doyle R. Judd, CFO - Mr. Doyle Judd is a solid, seasoned and value-added accounting and finance professional with over thirty years of experience. During his nine year tenure with Deloitte & Touche, he gained broad-based and valuable experience with publicly-held, Fortune 500 as well as smaller, private companies in a variety of industries. He leveraged his public accounting experience to become CFO of a $100 million, NASDAQ-listed, food service company from 1983 to 1993. This was followed by eleven years as CFO of two separate privately-held companies, one of which was early stage. He holds a Master of Accountancy degree from Brigham Young University, Marriott School of Management, and is a CPA. Stan Yakatan, MBA, Chairman - Mr. Stan Yakatan has thirty years experience as a CEO, entrepreneur, and operational manager for biotech and medical companies. Mr. Yakatan is on the board of directors of several public and private companies as well as an advisor to several of the world's leading venture capital firms and to the governments of Australia and Canada. Indira Pottathil, PhD, Director of International Marketing - Since 1996, Dr. Indira Pottathil has been Vice President of Research & Development at AccuDx Corporation where she managed compliance efforts as well as development and production of in vitro diagnostic products. Dr. Pottathil began her career at the University of Bombay's Cancer Research Institute where she was a Senior Scientist for six years, followed by five years as an Information Scientist with Schering Plough. She earned her doctorate in Applied Biology at the University of Bombay. Dr. Pottathil served as a Postdoctoral Research Associate at the Jackson Laboratory (Bar Harbor, Maine) and completed a Postdoctoral Fellowship at Duke University. Kim Liao, Director of Asian Business Developoment - Mr. Kim Liao previously held senior executive positions with Abbott Laboratories' Diagnostic Division in Taiwan, Medtronic Taiwan, and Becton Dickinson Worldwide (Taiwan). Seth Yakatan, MBA, Consultant, Business Developoment - Mr. Seth Yakatan is a partner of Katan Associates. Mr. Yakatan has successfully managed early-state partnering assignments and sell-side M&A engagements for companies in the Life Sciences sector. Seth serves as a board member for Technoprises/Apros & Chay, Ltd.


Contact Details:
17th Floor 3550 Wilshire Blvd.
Los Angeles
CA
90010
United States of America
Tel:(213) 637-5692
Fax:(213) 637-5691
Email:info@grantlifesciences.com
WWW:

www.grantlifesciences.com/index.asp




Loading...

BioNews Results for Grant Life Sciences:

Delcath Systems, Inc. Prices $30.6 Million Stock Offering
KOTA Territory News:  Nov 14 2009 11:05PM Matching: grant life sciences
Delcath Systems, Inc. Prices $30.6 Million Stock Offering
KSLA:  Nov 14 2009 7:28AM Matching: grant life sciences
Delcath Systems, Inc. Prices $30.6 Million Stock Offering
Genetic Engineering News:  Nov 13 2009 9:02AM Matching: grant life sciences
Delcath Systems, Inc. Prices $30.6 Million Stock Offering
Freshnews.com:  Nov 13 2009 2:12AM Matching: grant life sciences
Sequencing platform generates draft cassava genome
Laboratorytalk:  Nov 12 2009 2:56PM Matching: grant life sciences
Promote your company here: BioNewsCast - Press Release Distribution

View more Grant Life Sciences news.

Grant Life Sciences (GLIFE.OB) Financial information Links from Barchart

GLIFE.OB Quote from from Barchart.com
GLIFE.OB Chart from from Barchart.com
GLIFE.OB Profile from from Barchart.com
GLIFE.OB Opinion from from Barchart.com

View more Grant Life Sciences finance information.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 688 times since April 2007, the link to the organisation's website has been followed 88 times

Search for more companies in Los Angeles

Search for more companies in CA



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Grant Life Sciences

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.